V Alberola Candel
Overview
Explore the profile of V Alberola Candel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
37
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gasent Blesa J, Laforga Canales J, Candel V
Curr Oncol
. 2010 Apr;
17(2):64-8.
PMID: 20404981
The treatment of metastatic breast cancer is challenging. We recently assisted in the development of targeted therapies (in combination with chemotherapy or as monotherapy) that have improved results for selected...
2.
Gasent Blesa J, Candel V, Giner Marco V, Giner-Bosch V, Provencio Pulla M, Laforga Canales J
Ann Oncol
. 2010 Feb;
21(5):1131-2.
PMID: 20139153
No abstract available.
3.
Gasent Blesa J, Laforga Canales J, Soler A, Peiro Monzo F, Puche J, Candel V
Curr Oncol
. 2009 Oct;
16(5):76-80.
PMID: 19862364
Treatment of patients with metastatic colorectal cancer has changed in recent years, with many patients now being offered intent-to-treat regimens. In this context, a multidisciplinary approach to the metastatic disease...
4.
Gasent Blesa J, Candel V, Provencio Pulla M, Esteban Gonzalez E, Martin Algarra S
Clin Transl Oncol
. 2009 Jan;
11(1):35-40.
PMID: 19155202
Introduction: Platinum resistant ovarian cancer is a current challenge in Oncology. Current approved therapies offer no more of a 20% of response. New therapeutic options are urgently needed. Patients And...
5.
Gasent Blesa J, Candel V, Esteban Gonzalez E, Vidal Martinez J, Gisbert Criado R, Provencio Pulla M, et al.
Clin Transl Oncol
. 2008 Jul;
10(7):399-406.
PMID: 18628068
Breast cancer is the most common type of cancer among women, and clinicians have long recognized its heterogeneity. Its detection and treatment in early stages allow for reduction of mortality....
6.
Gasent Blesa J, Esteban Gonzalez E, Candel V
Clin Transl Oncol
. 2008 May;
10(5):274-80.
PMID: 18490244
Lung cancer is a major health problem due to its incidence and mortality. The risk factors, the existence of a preclinical phase, and the relationship between stage at diagnosis and...
7.
Carrion R, Candel V, Calabresi F, Michel R, Santos R, Delozier T, et al.
Ann Oncol
. 1994 Jan;
5 Suppl 7:S19-24.
PMID: 7873457
A total of 409 postmenopausal patients with advanced metastatic breast cancer were randomized to receive either formestane (Lentaron) 250 mg every 2 weeks by intramuscular injection, or tamoxifen 30 mg/day...
8.
Aguilar Ligorit E, Guix Garcia J, Benet Monforte I, Marugan de la Concha I, Escrig Orenga V, Pascual Lopez A, et al.
Med Clin (Barc)
. 1989 May;
92(17):641-5.
PMID: 2747329
In 24 cases of thrombopenic purpura associated with human immunodeficiency virus infection the clinical, immunological and therapeutic features were evaluated. Thrombopenia resulted in clinical manifestations in 20 patients. Splenomegaly was...
9.
Artero Mora A, Lluch Hernandez A, Cano Sanchez A, Bueno Canigral F, Martin Quetglas G, Candel V
Tumori
. 1989 Apr;
75(2):113-6.
PMID: 2741216
An immunoradiometric assay was used to determine the presence of p29 protein in 68 breast cancer cyTOSOLS. The p29 values ranged from 0 to 1123 U/mg, with a mean value...
10.
Aguilar Ligorit E, Guix Garcia J, Sanchez Fernandez de Sevilla C, Escrig Orenga V, Candel V, Llombart Bosch A
Med Clin (Barc)
. 1988 Sep;
91(7):256-60.
PMID: 3193832
No abstract available.